Josep Carreras Leukaemia Research Institute Revenue and Competitors
Estimated Revenue & Valuation
- Josep Carreras Leukaemia Research Institute's estimated annual revenue is currently $27.8M per year.
- Josep Carreras Leukaemia Research Institute's estimated revenue per employee is $112,200
Employee Data
- Josep Carreras Leukaemia Research Institute has 248 Employees.
- Josep Carreras Leukaemia Research Institute grew their employee count by 6% last year.
Josep Carreras Leukaemia Research Institute Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13M | 127 | 43% | N/A | N/A |
#2 | $11.2M | 110 | 62% | N/A | N/A |
#3 | $27.3M | 243 | 10% | N/A | N/A |
#4 | $26M | 237 | 25% | $11M | N/A |
#5 | $3.3M | 41 | -11% | N/A | N/A |
#6 | $11.6M | 114 | 24% | N/A | N/A |
#7 | $1.6M | 22 | 5% | N/A | N/A |
#8 | $5.9M | 64 | 10% | N/A | N/A |
#9 | $27.8M | 248 | 28% | N/A | N/A |
#10 | $3.7M | 45 | -56% | N/A | N/A |
What Is Josep Carreras Leukaemia Research Institute?
The Josep Carreras Leukaemia Research Institute was founded in 2010, by the Josep Carreras Foundation and the Government of Catalonia, as the first European research centre devoted exclusively to leukaemia and other malignant blood diseases, and one of the few that exist in the world. We investigate basic, epidemiological, preventive, clinical, and translational aspects of leukaemia and other hematologic malignancies. Our research aims to identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and development of leukaemias and other malignant haematological pathologies, to be able to prevent them. We work for a future in which all leukaemias will be curable. Our fight will endure until there's a cure.
keywords:N/A
N/A
Total Funding
248
Number of Employees
$27.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Josep Carreras Leukaemia Research Institute News
Credit: Josep Carreras Leukaemia Research Institute. Recent advances in immunotherapy open the door to new approaches in cancer treatments.
In this new study, researchers from the Wellcome Sanger Institute and the Josep Carreras Leukaemia Research Institute generated single-cell data...
New research from the Wellcome Sanger Institute, the Josep Carreras Leukaemia Research Institute in Spain and their collaborators,...
Other Companies in Badalona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $32.4M | 289 | 7% | N/A |
#2 | $217.9M | 601 | 84% | N/A |
#3 | $266.1M | 864 | 4% | N/A |